ibandronic acid
ItalyDrugs containing this active substance
-
Baxogar is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures. The drug helps to prevent bone loss and increase bone mass, reducing the possibility of spinal fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid - ATC: M05BA06
Manufacturer: PHARMACARE S.R.L.
-
This medicine is used for several conditions: in adults with breast cancer that has spread to the bones, it helps prevent fractures and other bone problems that might require surgery or radiotherapy; it can also be prescribed for high calcium levels in the blood caused by cancer. In other cases, it is used to treat postmenopausal osteoporosis in women at high risk of fractures.
Form: solution for infusion, concentrate
Active substance Dosage ibandronic acid - ATC: M05BA06
Manufacturer: ACCORD HEALTHCARE, S.L.U.
-
It is prescribed to treat postmenopausal osteoporosis in women with a high risk of fractures. The drug helps to block bone loss and increase bone mass, reducing the possibility of spinal fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid - ATC: M05BA06
Manufacturer: LABORATORI ALTER S.R.L.
-
It is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures. The drug helps to block bone loss and increase bone mass, reducing the risk of spinal fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid - ATC: M05BA06
Manufacturer: DOC GENERICI SRL
-
It is prescribed to treat osteoporosis in women with a high risk of fractures. The drug helps to block bone loss and increase bone mass, reducing the possibility of spinal fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid - ATC: M05BA06
Manufacturer: SANDOZ S.P.A.
-
This medicine is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures, or for adults with breast cancer that has spread to the bones (bone metastases), with the aim of preventing fractures and other bone problems.
Form: tablets, film-coated
Active substance Dosage ibandronic acid - ATC: M05BA06
Manufacturer: TECNIGEN S.R.L.
-
It is prescribed to treat postmenopausal osteoporosis in women at high risk of fractures. The drug helps to counteract bone loss and can decrease the possibility of spinal fractures.
Form: tablets, film-coated
Active substance Dosage ibandronic acid - ATC: M05BA06
Manufacturer: ZENTIVA ITALIA S.R.L.